Influenza Vaccine Market To Witness Huge Growth By 2030

1. Market Research Report EXCLUSIVE EDITION Influenza Vaccine Market Research Report Global Industry Analysis, Forecast and Trends, 2022-2030 © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

2. Global Influenza Vaccine Market © 2020 Statsville Consulting Private Limited Market Statsville Group (MSG) A part of Statsville Consulting Private Limited American Office American Office – 416, East Standsberry Street, Perkins, Oklahoma 74059, USA EMEA EMEA– 1165 Budapest 16 Diósy Lajos u. 24., Europe Asia Asia- -Pacific Office Pacific Office – F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 www.marketstatsville.com Disclaimer Disclaimer: : Any information and/or material provided by Statsville Consulting Private Limited, including any and all the analysis and/or research from Market Statsville Group (MSG), is offered to a selected group of customers in response to orders for such information, material, analysis, and/or research. As a customer of Statsville Consulting, you acknowledge that our information, material, and/or services are for your internal use only, and not for any external use and/or dissemination, or general publication, and/or disclosure to any third parties. Any and all the information and/or material provided by Statsville Consulting are based on primary interviews and/or secondary research, and are, therefore, subject to fluctuation and variance. Statsville Consulting takes no responsibility for any incorrect information and/or material supplied to us by sources we rely on, and no part of our analysis or research may be given, lent, resold, or disclosed to any third parties, including non-customers, without explicit or written permission from Statsville Consulting. Unauthorized reproduction and/or transmission of our information, material, analysis, and/or research in any form and by any means, including photocopying, mechanical/electronic recording,or otherwise, without the explicit and written permission of Statsville Consulting, is expressly and clearly prohibited. Any use of the information, material, analysis, and/or research provided by Statsville Consulting is at your sole risk; you acknowledge that the information, material, analysis, and/or research is provided “as is” and that Statsville Consulting provides no warranty of any kind, express or implied, with regard to the information, material, analysis, and/or research, including but not limited to, merchantability and fitness for any purpose and/or use. At the end, Statsville Consulting will be responsiblefor the final decision of any action. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

3. ABOUT MARKET STATSVILLE GROUP (MSG) Market Statsville Group (MSG) partners with companies and society to confront their essential risks and challenges to capture the enormous opportunities for them. MSG was initiated its working in 2017, and since then, the brand is moving to become a pioneer in business advisory and market research services. Market Statsville is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in the form of market sizing, analysis, and incisive business insights. MSG experienced research analysts are proficient at digging deep and providing a variety of customizable data that help you make decisions with clarity, confidence, and impact. Market Statsville is your global data intelligence partner for reliable market research data, data gathering, and analytical services. MSG also has an extensive network of top-flight domestic and global research personals around the world, enabling us to provide high-quality worldwide research solutions that cater to a well-established company, government organizations, or a startup. MSG's clients have the authority to work directly with one or more of our researchers to gather the most useful data knowledge and analytical plan to formulate it in the actual practice. Market Statsville Group believes that to succeed, companies or individuals must blend digital and human capabilities most efficiently. MSG diverse and experienced global team of business consultants and market researchers will ensure the valuable reports for our clients through digging in-depth market information and functional expertise to continuously spark the changes and real-time valuation of variation in the market/industry. MSG works in a uniquely collaborative model throughout the business process across the globe to assist the client's company with the most accurate information that they are aiming for in the reports. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

4. RESEARCH PROCESS Our research is an optimum culmination of secondary and primary research, with the latter playing a major role. We also have an in-house repository and access to a number of external regional and global paid databases to help address specific requirements of our clients. The research process begins with a holistic secondary research, followed by expert interviews. The information gathered is then comprehensively analyzed by our highly experienced in-house research panel © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

5. Influenza Vaccine Market Expectations and Growth Trends Highlighted Until 2030 Influenza Vaccine Market by Vaccine Type (Quadrivalent and Trivalent), Technology (Egg-based, and Cell culture), Age Group (Pediatric, and Adult), and Route of Administration (Injection, and Nasal Spray): Global Opportunity Analysis and Industry Forecast, 2022–2030 Description Description The global influenza vaccine market global influenza vaccine marketsize was valued at USD 5,117.24 11,276.32 11,276.32million by 2030 million by 2030, registering a CAGR of 7.67% from 2021 to 2030. The viral infection which occurs due to flu in the respiratory system is called influenza. The influenza virus travels through respiratory droplets and is contagious. It can also spread from one person to another while talking or in physical contact. The influenza virus circulates continuously, causing regional epidemics and outbreaks, which lead to thousands of deaths. The changing character of the virus is compelling an annual change in the vaccine strain to match the influenza virus strain. Healthcare organizations all over the world, like the Centers for Disease Control and Prevention (CDC), have suggested vaccines like baloxavir marboxil (Xofluza) for the treatment of influenza have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients. USD 5,117.24million in 2020 million in 2020 and is projected to reach USD USD The COVID-19 outbreak is anticipated to impact the global influenza vaccine market’s growth positively. The population affected by the COVID-19 virus increases, increasing the demand for influenza vaccines. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

6. The influenza vaccine will not prevent COVID-19 but decrease illness, death, and hospitalization. According to the European Congress of Clinical Microbiology & infectious diseases (ECCMID), in 2021, it was reported that around 75,000 COVID-19 patients having a shot of influenza vaccine are less prone to sepsis, stroke, and deep vein thrombosis. As per the same source, in 2021, it was observed that the flu vaccine might offer protection against the COVID-19 virus. The patient suffering from COVID-19 and vaccinated with influenza vaccine is also less likely to be admitted to the intensive care unit. Subsequently, this leads to an increase in demand for the influenza vaccine. Get PDF for more Professional and Technical insights: Get PDF for more Professional and Technical insights:https://www.marketstatsville.com/request https://www.marketstatsville.com/request- -sample/influenza sample/influenza- -vaccine vaccine- -market market The vaccines used for influenza are three different influenza viruses: type A with H3N2 virus strain, type A with H1N1 virus strain and type B virus strain. An increase in the prevalence of influenza epidemics and seasonal outbreaks is likely to expand the product sales during the projected period. An increase in government support and surveillance regarding vaccination against influenza on the national and global levels to monitor the supply, distribution, and administration of flu vaccines is one of the crucial factors driving the market growth. Moreover, an increase in investment by leading market players across the globe and a rise in government funding has facilitated the launch of therapeutically effective vaccines drive the influenza vaccine market growth. The immunization camps and programs conducted by various healthcare organizations have been affected due to the coronavirus pandemic. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

7. The vaccination rates for flu have peaked in the pandemic due to a push by various healthcare operatives and governments who are providing free vaccination to the citizens. Awareness has also raised amongst the populations due to the fear of flu and COVID-19. Novel vaccine development is a huge process that generally takes about 10-15 years to develop and establish its safety and efficacy. Regulatory requirements for clinical trials vary in countries, which may delay the development of vaccines and limit the market’s growth. Many companies like Sanofi, Emergent BioSolutions Inc., and F. Hoffmann-La Roche Ltd are also helping in the distribution. On the other hand, many countries face undersupplies and delay in the approvals of vaccines and availability of vaccines due to the strict regulations during the clinical trials extending the timelines of vaccines delivery. Global Influenza Vaccine Market Segmentation: Global Influenza Vaccine Market Segmentation: The influenza vaccine market is segmented into vaccine type, technology, age group, route of administration, and region. By vaccine type, it is divided into quadrivalent and trivalent. By technology, it is classified into egg-based and cell-based. By age group, it is divided into pediatric and adult. By route of administration, it is categorized into injection and nasal spray. Region- wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA). © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

8. You Can Purchase Complete Report@ https://www.marketstatsville.com/buy-now/influenza-vaccine- market?opt=2950 By Vaccine Type, the Influenza Vaccine Market is segmented into By Vaccine Type, the Influenza Vaccine Market is segmented into- - Quadrivalent Trivalent By vaccine type, it is divided into quadrivalent and trivalent. The quadrivalent type segment was the major revenue contributor in 2020, owing to its ability to immunize four influenza virus strains (two A subtypes and two B subtypes — H1N1 and H3N2 and Victoria and Yamagata, respectively). By technology, it is classified into egg-based and cell-based. By Type By Type Seasonal Pandemic By By Technology Technology Egg-based Cell-based The egg-based technology segment dominates the technology segment as it is most commonly used to produce both inactivated and live-attenuated vaccines. By age group, it is bifurcated into pediatric and adult. The adult age group segment was the highest contributor in the influenza vaccine market in 2020 and is expected to remain dominant during the forecast period, owing to higher risks of developing serious complications from influenza due to weaker immune responses. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

9. By Age Group •Pediatric •Adult Access full Report Description, Access full Report Description,TOC, Table of Figure, Chart, etc. TOC, Table of Figure, Chart, etc. @ https://www.marketstatsville.com/table-of-content/influenza- vaccine-market By Route Of Administration By Route Of Administration Injection Nasal Spray By Region By Region North America The US. Canada Mexico © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

10. Europe Germany France UK Italy Spain Rest of Europe Asia-Pacific Australia Japan India China South Korea Rest of Asia-Pacific Latin America Brazil Rest of Latin America The Middle East and Africa Saudi Arabia South Africa © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | Rest of the Middle East and Africa +1-580-205-2707 | +91-702-496-8807

11. Latin America Brazil Rest of Latin America The Middle East and Africa Saudi Arabia South Africa Rest of the Middle East and Africa North America accounted for the largest influenza vaccine market share in 2020 and is expected to retain its dominance throughout the forecast period. This is attributed to the increased prevalence of influenza in the region, increased government focus on immunization programs, the emergence of new vaccines, and growth in technological advancements for vaccine administration. However, the Middle East and Africa are expected to emerge as lucrative areas with maximum growth potential due to increased awareness programs, improvement in healthcare facilities, available disposable income, and rapid development of economic conditions. Request For Report Description @ Request For Report Description @ https://www.marketstatsville.com/influenza https://www.marketstatsville.com/influenza- -vaccine vaccine- -market market Key Players for Global Influenza Vaccine Market Report: Key Players for Global Influenza Vaccine Market Report: © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

12. Astrazeneca Plc (Astrazeneca) Biodiem Csl Limited (Seqirus GmbH) Emergent Biosolutions F. Hoffmann-La Roche Ltd. Gamma Vaccines Pty Ltd. GlaxoSmithKline Plc Merck & Co., Inc. (Merck Sharp & Dohme Corp.) Novartis Ag Pfizer, Inc. Sanofi Sinovac Biotech Ltd. © Statsville Consulting Private Limited www.marketstatsville.com | sales@marketstatsville.com | +1-580-205-2707 | +91-702-496-8807

13. Thank You Thank You Market Market Statsville Statsville Group (MSG) Group (MSG) F-178 Subhash Marg C Scheme, Ashok Nagar, Jaipur, Rajasthan, 302001 Phone : +91 702 496 8807 Mail : sales@marketstatsville.com 416, East Standsberry Street, Perkins, Oklahoma 74059, US Phone : +1 580 250 2707 Mail : sales@marketstatsville.com